These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28671114)

  • 1. Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition.
    Stephen R; Liu Y; Ngandu T; Rinne JO; Kemppainen N; Parkkola R; Laatikainen T; Paajanen T; Hänninen T; Strandberg T; Antikainen R; Tuomilehto J; Keinänen Kiukaanniemi S; Vanninen R; Helisalmi S; Levälahti E; Kivipelto M; Soininen H; Solomon A
    J Alzheimers Dis; 2017; 59(2):695-705. PubMed ID: 28671114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging.
    Vuorinen M; Spulber G; Damangir S; Niskanen E; Ngandu T; Soininen H; Kivipelto M; Solomon A
    J Alzheimers Dis; 2015; 44(1):93-101. PubMed ID: 25190628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis.
    Stephen R; Ngandu T; Liu Y; Peltonen M; Antikainen R; Kemppainen N; Laatikainen T; Lötjönen J; Rinne J; Strandberg T; Tuomilehto J; Vanninen R; Soininen H; Kivipelto M; Solomon A;
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1407-1414. PubMed ID: 33970268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study.
    Kemppainen N; Johansson J; Teuho J; Parkkola R; Joutsa J; Ngandu T; Solomon A; Stephen R; Liu Y; Hänninen T; Paajanen T; Laatikainen T; Soininen H; Jula A; Rokka J; Rissanen E; Vahlberg T; Peltoniemi J; Kivipelto M; Rinne JO
    Neurology; 2018 Jan; 90(3):e206-e213. PubMed ID: 29263220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults.
    Ecay-Torres M; Estanga A; Tainta M; Izagirre A; Garcia-Sebastian M; Villanua J; Clerigue M; Iriondo A; Urreta I; Arrospide A; Díaz-Mardomingo C; Kivipelto M; Martinez-Lage P
    Neurology; 2018 Jul; 91(3):e217-e226. PubMed ID: 29898969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia.
    Enache D; Solomon A; Cavallin L; Kåreholt I; Kramberger MG; Aarsland D; Kivipelto M; Eriksdotter M; Winblad B; Jelic V
    Neurobiol Aging; 2016 Jun; 42():124-31. PubMed ID: 27143429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER).
    Stephen R; Liu Y; Ngandu T; Antikainen R; Hulkkonen J; Koikkalainen J; Kemppainen N; Lötjönen J; Levälahti E; Parkkola R; Pippola P; Rinne J; Strandberg T; Tuomilehto J; Vanninen R; Kivipelto M; Soininen H; Solomon A;
    Alzheimers Res Ther; 2019 Jun; 11(1):53. PubMed ID: 31164160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Dementia and Vascular Risk Scores With Cortical Thickness and Cognition in Low-risk Middle-aged Adults.
    Gourley D; Pasha EP; Kaur SS; Haley AP; Tanaka H
    Alzheimer Dis Assoc Disord; 2020; 34(4):313-317. PubMed ID: 32467426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Vascular Risk Score and CAIDE Dementia Risk Score Predict Cognitive Function in the Northern Manhattan Study.
    Rundek T; Gardener H; Dias Saporta AS; Loewenstein DA; Duara R; Wright CB; Dong C; Levin B; Elkind MSV; Sacco RL
    J Alzheimers Dis; 2020; 73(3):1221-1231. PubMed ID: 31884476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.
    Lane CA; Barnes J; Nicholas JM; Sudre CH; Cash DM; Malone IB; Parker TD; Keshavan A; Buchanan SM; Keuss SE; James SN; Lu K; Murray-Smith H; Wong A; Gordon E; Coath W; Modat M; Thomas D; Richards M; Fox NC; Schott JM
    JAMA Neurol; 2020 Feb; 77(2):175-183. PubMed ID: 31682678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.
    Wennberg AM; Gustafson D; Hagen CE; Roberts RO; Knopman D; Jack C; Petersen RC; Mielke MM
    J Alzheimers Dis; 2016 May; 53(2):573-81. PubMed ID: 27163809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Brain Integrity in the Association between Occupational Complexity and Cognitive Performance in Subjects with Increased Risk of Dementia.
    Rydström A; Stephen R; Kåreholt I; Darin Mattsson A; Ngandu T; Lehtisalo J; Bäckman L; Kemppainen N; Rinne J; Sindi S; Soininen H; Vanninen R; Solomon A; Mangialasche F
    Gerontology; 2023; 69(8):972-985. PubMed ID: 37071974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.
    Lopez OL; Klunk WE; Mathis C; Coleman RL; Price J; Becker JT; Aizenstein HJ; Snitz B; Cohen A; Ikonomovic M; McDade E; DeKosky ST; Weissfeld L; Kuller LH
    Neurology; 2014 Nov; 83(20):1804-11. PubMed ID: 25305156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Amyloid affects frontal and posterior brain networks in normal aging.
    Oh H; Mormino EC; Madison C; Hayenga A; Smiljic A; Jagust WJ
    Neuroimage; 2011 Feb; 54(3):1887-95. PubMed ID: 20965254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline.
    Pekkala T; Hall A; Ngandu T; van Gils M; Helisalmi S; Hänninen T; Kemppainen N; Liu Y; Lötjönen J; Paajanen T; Rinne JO; Soininen H; Kivipelto M; Solomon A
    Front Aging Neurosci; 2020; 12():228. PubMed ID: 32848707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
    Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
    Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
    Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
    J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Susceptibility Mapping of Brain Iron and β-Amyloid in MRI and PET Relating to Cognitive Performance in Cognitively Normal Older Adults.
    Chen L; Soldan A; Oishi K; Faria A; Zhu Y; Albert M; van Zijl PCM; Li X
    Radiology; 2021 Feb; 298(2):353-362. PubMed ID: 33231528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
    Scheinin NM; Aalto S; Koikkalainen J; Lötjönen J; Karrasch M; Kemppainen N; Viitanen M; Någren K; Helin S; Scheinin M; Rinne JO
    Neurology; 2009 Oct; 73(15):1186-92. PubMed ID: 19726751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.